Zerico Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.32 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.77 Cr
as on 16-11-2024
- Revenue -3.10%
(FY 2023)
- Profit 17.62%
(FY 2023)
- Ebitda 13.61%
(FY 2023)
- Net Worth 16.79%
(FY 2023)
- Total Assets -1.43%
(FY 2023)
About Zerico Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.32 Cr. The company has closed loans amounting to ₹4.77 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sachinkumar Shukla, Sangeeta Shukla, and Rajeev Ranjan serve as directors at the Company.
- CIN/LLPIN
U51101MH2013PTC249390
- Company No.
249390
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Zerico Lifesciences Private Limited offer?
Zerico Lifesciences Private Limited offers a wide range of products and services, including Popular Category, Bone & Joint Care.
Who are the key members and board of directors at Zerico Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Ranjan  | Director | 14-Nov-2013 | Current |
| Sachinkumar Shukla | Director | 18-Oct-2013 | Current |
| Sangeeta Shukla | Director | 18-Oct-2013 | Current |
Financial Performance of Zerico Lifesciences.
Zerico Lifesciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.1% decrease. The company also saw a substantial improvement in profitability, with a 17.62% increase in profit. The company's net worth Soared by an impressive increase of 16.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zerico Lifesciences?
In 2023, Zerico Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 24 Nov 2021 | ₹4.32 Cr | Open |
Others Creation Date: 12 Nov 2020 | ₹3.25 M | Satisfied |
Others Creation Date: 29 Jan 2020 | ₹3.75 Cr | Satisfied |
How Many Employees Work at Zerico Lifesciences?
Zerico Lifesciences has a workforce of 171 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zerico Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zerico Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
